Poor effect of guideline based treatment of restless legs syndrome in clinical practice

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 81, Issue 12, 2010, Pages 1390-1395

  Godau, Jana ^a   Spinnler, Nike ^a   Wevers, Anne Kathrin ^a   Trenkwalder, Claudia ^b   Berg, Daniela ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CABERGOLINE; GABAPENTIN; LEVODOPA; PRAMIPEXOLE; ROPINIROLE; ROTIGOTINE; TILIDINE; TRAMADOL;

ADULT; ARTICLE; CHRONIC PAIN; CLINICAL PRACTICE; COMORBIDITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; RESTLESS LEGS SYNDROME; SOMATOFORM DISORDER;

EID: 78649631447     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2010.211417     Document Type: Article

References (28)

1. Berger K, von Eckardstein A, Trenkwalder C, et al. Iron metabolism and the risk of restless legs syndrome in an elderly general population - the MEMO-Study. J Neurol 2002;249:1195-9.
2. Trenkwalder C, Hening WA, Montagna P, et al. Treatment of restless legs syndrome: an evidence-based review and implications for clinical practice. Mov Disord 2008;23:2267-302.
3. Tison F, Crochard A, Leger D, et al. Epidemiology of restless legs syndrome in French adults: a nationwide survey: the INSTANT Study. Neurology 2005;65:239-46.
4. Allen RP, Walters AS, Montplaisir J, et al. Restless legs syndrome prevalence and impact: REST general population study. Arch Intern Med 2005;165:1286-92.
5. Kushida CA. Clinical presentation, diagnosis, and quality of life issues in restless legs syndrome. Am J Med 2007;120(Suppl 1):S4-12.
6. Sevim S, Dogu O, Kaleagasi H, et al. Correlation of anxiety and depression symptoms in patients with restless legs syndrome: a population based survey. J Neurol Neurosurg Psychiatry 2004;75:226-30.
7. Winkelmann J, Prager M, Lieb R, et al. "Anxietas tibiarum". Depression and anxiety disorders in patients with restless legs syndrome. J Neurol 2005;252:67-71.
8. Lee HB, Hening WA, Allen RP, et al. Restless legs syndrome is associated with DSM-IV major depressive disorder and panic disorder in the community. J Neuropsychiatry Clin Neurosci 2008;20:101-5.
9. Ulfberg J, Nystrom B, Carter N, et al. Prevalence of restless legs syndrome among men aged 18 to 64 years: an association with somatic disease and neuropsychiatric symptoms. Mov Disord 2001;16:1159-63.
10. Ulfberg J, Bjorvatn B, Leissner L, et al. Comorbidity in restless legs syndrome among a sample of Swedish adults. Sleep Med 2007;8:768-72.
11. Shaver JL, Wilbur J, Robinson FP, et al. Women's health issues with fibromyalgia syndrome. J Womens Health (Larchmt) 2006;15:1035-45.
12. Stehlik R, Arvidsson L, Ulfberg J. Restless legs syndrome is common among female patients with fibromyalgia. Eur Neurol 2009;61:107-11.
13. Borek LL, Kohn R, Friedman JH. Phenomenology of dreams in Parkinson's disease. Mov Disord 2007;22:198-202.
14. Sabayan B, Bagheri M, Borhani Haghighi A. Possible joint origin of restless leg syndrome (RLS) and migraine. Med Hypotheses 2007;69:64-6.
15. Trenkwalder C, Hogl B, Benes H, et al. Augmentation in restless legs syndrome is associated with low ferritin. Sleep Med 2008;9:572-4.
16. Frauscher B, Gschliesser V, Brandauer E, et al. The severity range of restless legs syndrome (RLS) and augmentation in a prospective patient cohort: association with ferritin levels. Sleep Med 2009;10:611-15.
17. Walters AS, Rye DB. Review of the relationship of restless legs syndrome and periodic limb movements in sleep to hypertension, heart disease, and stroke. Sleep 2009;32:589-97.
18. Hogl B, Gschliesser V. RLS assessment and sleep questionnaires in practicedlessons learned from Parkinson's disease. Sleep Med 2007;8(Suppl 2):S7-12.
19. Walters AS, LeBrocq C, Dhar A, et al. Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. Sleep Med 2003;4:121-32.
20. Abetz L, Vallow SM, Kirsch J, et al. Validation of the restless legs syndrome quality of life questionnaire. Value Health 2005;8:157-67.
21. Spitzer RL, Kroenke K, Williams JB. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. JAMA 1999;282:1737-44.
22. Garcia-Borreguero D, Allen RP, Kohnen R, et al. Diagnostic standards for dopaminergic augmentation of restless legs syndrome: report from a World Association of Sleep Medicine-International Restless Legs Syndrome Study Group consensus conference at the Max Planck Institute. Sleep Med 2007;8:520-30.
23. Garcia-Borreguero D, Kohnen R, Hogl B, et al. Validation of the Augmentation Severity Rating Scale (ASRS): a multicentric, prospective study with levodopa on restless legs syndrome. Sleep Med 2007;8:455-63.
24. Hautzinger M. The beck depression inventory in clinical practice. Nervenarzt 1991;62:689-96.
25. Bloch KE, Schoch OD, Zhang JN, et al. German version of the Epworth Sleepiness Scale. Respiration 1999;66:440-7.
26. Winkelmann J, Wetter TC, Collado-Seidel V, et al. Clinical characteristics and frequency of the hereditary restless legs syndrome in a population of 300 patients. Sleep 2000;23:597-602.
27. Hornyak M, Grossmann C, Kohnen R, et al. Cognitive behavioural group therapy to improve patients' strategies for coping with restless legs syndrome: a proof-of-concept trial. J Neurol Neurosurg Psychiatry 2008;79:823-5.
28. Reinhardt M, Junge P, Staub U, et al. Iodine deficiency in Southern Badenia - changes during the last 55 years. Nuklearmedizin 1995;34:15-19.